Tuesday, June 30, 2015 5:19:09 PM
Whilst we have raised the previosly estimated $2million required to obtain US Food and Drug Administration approval
of the patented process for humans and to make the product available to our targeted markets our due diligence has
been successfully completed and contracts now signed subject only to the remittance and clearance of funds.The
new loan investment in the Company will allow trials to recommence. The delay in receiving the new funding, due to
circumstances beyond our control or influence, has prevented us from pursuing the FDA approval, appointing our
preferred investor relations and public relations consultants and commissioning the new website.
http://www.otcmarkets.com/financialReportViewer?symbol=TCEL&id=138904
You should not make any trades or decisions based upon anything said or written by posts on this board with regard to investments without consulting a professional financial planner/adviser..
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM